Crossref
Varenicline reduces cannabis use in men in Phase 2 trial
The Brown University Psychopharmacology Update · 2026-06 · 37 (6) · 7-7
DOI: 10.1002/pu.31454 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 30.04.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Varenicline reduces cannabis use in men in Phase 2 trial. The Brown University Psychopharmacology Update, 37(6), 7-7. https://doi.org/10.1002/pu.31454
Vancouver
Varenicline reduces cannabis use in men in Phase 2 trial. The Brown University Psychopharmacology Update. 2026;37(6):7-7. doi:10.1002/pu.31454
BibTeX
@article{euvimed2026,
title = {Varenicline reduces cannabis use in men in Phase 2 trial},
journal = {The Brown University Psychopharmacology Update},
year = {2026},
volume = {37},
number = {6},
pages = {7--7},
doi = {10.1002/pu.31454}
}
EUVIMED